Miller, Sophia S.
Mantell, Joanne E.
Parmley, Lauren E.
Musuka, Godfrey
Chingombe, Innocent
Mapingure, Munyaradzi
Rogers, John H.
Wu, Yingfeng
Hakim, Avi J.
Mugurungi, Owen
Samba, Chesterfield
Harris, Tiffany G.
Funding for this research was provided by:
U.S. president’s emergency plan for aids relief (NU2GGH00193)
Article History
Accepted: 9 February 2022
First Online: 18 March 2022
Declarations
:
: The authors do not have any conflicts of interest to declare.
: All procedures were approved by the Columbia University Irving Medical Center Institutional Review Board and the Medical Research Council of Zimbabwe. The protocol was also reviewed in accordance with the US Centers for Disease Control and Prevention (CDC) human research protection procedures and was determined to be research, but CDC investigators did not interact with human subjects or have access to identifiable data or specimens for research purposes.
: The survey was explained to eligible participants and if the person was interested, written, informed consent was obtained. Participants provided separate consent for each survey component: (1) completion of the questionnaire; (2) provision of venous blood for each biomarker test and storage for future testing; and (3) permission to be contacted by survey staff for follow-up. A copy of the signed consent form was provided to each participant.
: Not applicable.